2024-10-12 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, consumables, and services for research, analysis, and diagnostics.

**1. Performance vs. S&P 500 (VOO):**

* **TMO Cumulative Return:** 238.28%
* **VOO Cumulative Return:** 134.11%
* **Performance Gap:** 104.17%
* **Relative Performance:** 48.24% (Currently positioned at 48.24% of the historical performance gap range, which spans from -3.86% to 216.12%).

**2. Recent Price Action:**

* **Closing Price:** 592.04
* **5-day Moving Average:** 596.84
* **20-day Moving Average:** 608.34
* **60-day Moving Average:** 603.26

**3. Technical Indicators:**

* **RSI:** 34.45 (Suggests the stock is currently in oversold territory)
* **PPO:** -0.44 (Indicates bearish momentum)
* **Delta_Previous_Relative_Divergence:** -8.85 (Indicates a short-term downward trend)
* **Expected_Return:** 27.33% (Represents the projected 5-year return, exceeding S&P 500 returns)

**4. Recent Earnings and Outlook:**

| Date        | EPS   | Revenue |
|-------------|-------|---------|
| 2024-08-02 | 4.05  | 10.54 B$ |
| 2024-05-03 | 3.47  | 10.35 B$ |
| 2023-11-03 | 4.44  | 10.57 B$ |
| 2023-08-04 | 3.53  | 10.69 B$ |
| 2024-08-02 | 3.53  | 10.69 B$ |

The most recent earnings report (2024-08-02) showed EPS of 4.05, exceeding analyst expectations. Revenue also beat estimates, indicating strong performance. 

**5. News and Recent Developments:**

* **Recent Market Outlook:** Thermo Fisher Scientific remains a leader in the scientific instrumentation and consumables market. The company's strong research and development capabilities, combined with its diversified product portfolio, continue to drive growth.
* **Analyst Opinions:**  Many analysts maintain a positive outlook on TMO, citing its robust financials, strong market position, and growth prospects.
* **Performance Highlights:**  Thermo Fisher Scientific has consistently delivered strong earnings and revenue growth. The company continues to expand its market share and invest in new technologies, positioning itself for further success.

**6. Overall Analysis:**

Thermo Fisher Scientific is a solid company with a history of strong performance. While the stock is currently in oversold territory, its long-term prospects remain positive. The recent earnings beat and analyst sentiment suggest that the company is well-positioned for continued growth. Investors seeking a stable and profitable investment may find TMO an attractive option.

**7. Recommendations:**

* **Long-Term Investment:** Consider a long-term investment in TMO, given its strong fundamentals and growth potential. 
* **Potential Buy Point:**  Monitor the RSI and PPO indicators for potential buy signals.
* **Risk:** Be mindful of potential market volatility and sector-specific risks.

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. It is crucial to conduct your own due diligence and consult with a qualified financial advisor before making any investment decisions. 
